Targeting Autoantigens to Overcome Allogeneic Treg Rejection & Enhance Therapeutic Success

2:15 pm - Tuesday 24th March 2026

  • Discussing interactions between the immune system and allogeneic Tregs to identify rejection mechanisms
  • Investigating opportunities to define and target autoantigens key to allogeneic Treg rejection
  • Strategies to remove or modify autoantigens to enhance persistence and prevent treatment rejection

Speakers:

Associate Director
GentiBio